200,000+ products from a single source!

sales@angenechem.com

Home > Carboxes > 148589-13-3

148589-13-3

148589-13-3 | 1H-Purine-2,6-dione, 8-[2-(3-chlorophenyl)ethenyl]-3,7-dihydro-1,3,7-trimethyl-

CAS No: 148589-13-3 Catalog No: AG001L1Q MDL No:

Product Description

Catalog Number:
AG001L1Q
Chemical Name:
1H-Purine-2,6-dione, 8-[2-(3-chlorophenyl)ethenyl]-3,7-dihydro-1,3,7-trimethyl-
CAS Number:
148589-13-3
Molecular Formula:
C16H15ClN4O2
Molecular Weight:
330.7689
IUPAC Name:
8-[(E)-2-(3-chlorophenyl)ethenyl]-1,3,7-trimethylpurine-2,6-dione
InChI:
InChI=1S/C16H15ClN4O2/c1-19-12(8-7-10-5-4-6-11(17)9-10)18-14-13(19)15(22)21(3)16(23)20(14)2/h4-9H,1-3H3/b8-7+
InChI Key:
WBWFIUAVMCNYPG-BQYQJAHWSA-N
SMILES:
Clc1cccc(c1)C=Cc1nc2c(n1C)c(=O)n(c(=O)n2C)C

Properties

Complexity:
526  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
1  
Exact Mass:
330.088g/mol
Formal Charge:
0
Heavy Atom Count:
23  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
330.772g/mol
Monoisotopic Mass:
330.088g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
58.4A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.5  

Literature

Title Journal
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. Bioorganic & medicinal chemistry 20131201
The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2. Neurotoxicity research 20120801
Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats. Neurotoxicity research 20120201
CSC counteracts l-DOPA-induced overactivity of the corticostriatal synaptic ultrastructure and function in 6-OHDA-lesioned rats. Brain research 20110227
Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes. American journal of physiology. Heart and circulatory physiology 20100201
Adenosine receptor interactions alter cardiac contractility in rat heart. Clinical and experimental pharmacology & physiology 20100101
Synthesis and in vitro evaluation of pteridine analogues as monoamine oxidase B and nitric oxide synthase inhibitors. Bioorganic & medicinal chemistry 20091101
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. Nature chemical biology 20091001
Co-administration of the partial dopamine D2 agonist terguride with L-dopa attenuates L-dopa-induced locomotor sensitization in hemiparkinsonian mice. Behavioural brain research 20090914
Inhibitory effect of 8-(3-chlorostryryl) caffeine on levodopa-induced motor fluctuation is associated with intracellular signaling pathway in 6-OHDA-lesioned rats. Brain research 20090618
Inhibition of monoamine oxidase by (E)-styrylisatin analogues. Bioorganic & medicinal chemistry letters 20090501
Modification of the cardiovascular response of posterior hypothalamic adenosine A(2A) receptor stimulation by adenylate cyclase and KATP channel blockade in anesthetized rats. Autonomic neuroscience : basic & clinical 20090312
Ginsenosides attenuate kainic acid-induced synaptosomal oxidative stress via stimulation of adenosine A(2A) receptors in rat hippocampus. Behavioural brain research 20090130
Effects of adenosine receptor antagonists on amitriptyline-induced QRS prolongation in isolated rat hearts. Clinical toxicology (Philadelphia, Pa.) 20080801
CSC, an adenosine A(2A) receptor antagonist and MAO B inhibitor, reverses behavior, monoamine neurotransmission, and amino acid alterations in the 6-OHDA-lesioned rats. Brain research 20080129
The participation of adenosine receptors in the adenosine 5'-triphosphate-induced relaxation in the isolated rabbit corpus cavernosum penis. International journal of urology : official journal of the Japanese Urological Association 20070801
Adenosine stimulates the basolateral 50 pS K channels in the thick ascending limb of the rat kidney. American journal of physiology. Renal physiology 20070701
Effect of 2-(6-cyano-1-hexyn-1-yl)adenosine on ocular blood flow in rabbits. Life sciences 20070227
Effects of adenosine receptor antagonists on amitriptyline-induced vasodilation in rat isolated aorta. Clinical toxicology (Philadelphia, Pa.) 20070101
Nucleotide analogues with immunobiological properties: 9-[2-Hydroxy-3-(phosphonomethoxy)propyl]-adenine (HPMPA), -2,6-diaminopurine (HPMPDAP), and their N6-substituted derivatives. European journal of pharmacology 20060701
Reversion of levodopa-induced motor fluctuations by the A2A antagonist CSC is associated with an increase in striatal preprodynorphin mRNA expression in 6-OHDA-lesioned rats. Synapse (New York, N.Y.) 20060601
Inhibition of monoamine oxidase B by analogues of the adenosine A2A receptor antagonist (E)-8-(3-chlorostyryl)caffeine (CSC). Bioorganic & medicinal chemistry 20060515
Purine P1 receptor-dependent immunostimulatory effects of antiviral acyclic analogues of adenine and 2,6-diaminopurine. European journal of pharmacology 20060113
Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. American journal of physiology. Heart and circulatory physiology 20060101
Supersensitivity of P2X receptors in cerebrocortical cell cultures after in vitro ischemia. Journal of neurochemistry 20051201
Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways. Experimental brain research 20050901
2-(1-Hexyn-1-yl)adenosine-induced intraocular hypertension is mediated via K+ channel opening through adenosine A2A receptor in rabbits. European journal of pharmacology 20050822
Pharmacological preconditioning with resveratrol: role of CREB-dependent Bcl-2 signaling via adenosine A3 receptor activation. American journal of physiology. Heart and circulatory physiology 20050101
Isolated rat inferior mesenteric artery response to adenosine: possible participation of Na+/K+-ATPase and potassium channels. Pharmacological reports : PR 20050101
Effects of adenosine on optic nerve head circulation in rabbits. Experimental eye research 20041101
PAP 9704, a Korean herbal medicine attenuates methamphetamine-induced hyperlocomotion via adenosine A2A receptor stimulation in mice. Biological & pharmaceutical bulletin 20040601
Inosine stimulates chemotaxis, Ca2+-transients and actin polymerization in immature human dendritic cells via a pertussis toxin-sensitive mechanism independent of adenosine receptors. Journal of cellular physiology 20040401
NECA and bradykinin at reperfusion reduce infarction in rabbit hearts by signaling through PI3K, ERK, and NO. Journal of molecular and cellular cardiology 20040301
Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum. Brain research 20040220
Genetic and pharmacological inactivation of the adenosine A2A receptor attenuates 3-nitropropionic acid-induced striatal damage. Journal of neurochemistry 20040201
Do adenosine receptors play a role in amitriptyline-induced cardiovascular toxicity in rats? Journal of toxicology. Clinical toxicology 20040101
Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways. Journal of cellular biochemistry 20030801
Interactive role of adenosine and dopamine in the opiate withdrawal syndrome. Naunyn-Schmiedeberg's archives of pharmacology 20030801
Cytokine-purine interactions in behavioral depression in rats. Integrative physiological and behavioral science : the official journal of the Pavlovian Society 20030101
Adenosine A2A antagonism reverses levodopa-induced motor alterations in hemiparkinsonian rats. Synapse (New York, N.Y.) 20021215
8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism. The Journal of biological chemistry 20020927
Coronary function and adenosine receptor-mediated responses in ischemic-reperfused mouse heart. Cardiovascular research 20020701
[In vivo investigation of the A2A adenosine receptor distribution using the [11C]-CSC radioligand]. Orvosi hetilap 20020526
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells. The Journal of biological chemistry 20020419
Immunoregulation of IL-6 secretion by endogenous and exogenous adenosine and by exogenous purinergic agonists in splenic tissue slices. Journal of neuroimmunology 20020401
Systemic adenosine given after ischemia protects renal function via A(2a) adenosine receptor activation. American journal of kidney diseases : the official journal of the National Kidney Foundation 20010901
Antiadrenergic effects of adenosine in pressure overload hypertrophy. Hypertension (Dallas, Tex. : 1979) 20010301
The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America 20010213
Preparation and primary evaluation of [11C]CSC as a possible tracer for mapping adenosine A2A receptors by PET. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 19990501
Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration. Neuroscience 19990301
Selective adenosine A2A receptor/dopamine D2 receptor interactions in animal models of schizophrenia. European journal of pharmacology 19960111
Adenosine antagonists potentiate D2 dopamine-dependent activation of Fos in the striatopallidal pathway. Neuroscience 19951001
A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Molecular pharmacology 19940601
Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists. Journal of medicinal chemistry 19930514

Related Products

© 2019 Angene International Limited. All rights Reserved.